The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.
HistoSonics raises $250M to expand use of noninvasive cancer therapy Read More »
The investment values the smart-ring maker at $11 billion.
Ōura raises $900M to develop new health features Read More »
La tecnología avanza a un ritmo que supera la capacidad de las personas para comprender su uso. Este proceso es continuo y abre oportunidades ilimitadas para la innovación en una amplia gama de industrias. En el segmento de la visión nocturna, el desarrollo depende casi por comp …
Cómo influye la tecnología en el desarrollo de los dispositivos de visión nocturna Read More »
Roche will gain worldwide rights outside of the Greater China region to Hansoh’s HS-20110, an antibody-drug conjugate in early-stage development for colorectal cancer.
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet Read More »
States have just weeks to submit their applications for the new Rural Health Transformation Program, but the CMS says its ability to provide support may be delayed due to the government shutdown.
CMS slows technical support for rural health fund despite looming deadline Read More »
CMS Administrator Mehmet Oz clarified that a deal has not yet been sealed with the manufacturer of semaglutide, Novo Nordisk, or any other GLP-1 drugmaker.
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic Read More »
EMD Serono will offer its fertility treatments on TrumpRx at a steep discount, and Roche’s direct-to-consumer offering will cover its flu pill Xofluza.
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program Read More »
With more than $1.5 billion on the line, Gilead looks to bolster its CAR T portfolio.
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back Read More »
The Commissioner’s National Priority Voucher awards companies that align with specific national priorities—such as boosting domestic manufacturing and lowering drug prices—with faster reviews and more frequent interactions with the FDA.
FDA Hands Out First Commissioner’s Priority Vouchers to Regeneron, Sanofi, Disc, Others Read More »
Una nueva especie de dinosaurio, a la cual se le ha dado el nombre de Astigmasaura genuflexa, ha sido descubierta y descrita científicamente. El hallazgo lo hicieron investigadores del Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) en Argentina, ju …
Especie de dinosaurio saurópodo, desconocida hasta ahora, de hace 95 millones de años Read More »
